TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33214446

Group type: EXPERIMENTAL
Intervention: Preoperative hepatic and regional arterial chemotherapy (PHRAC) plus adjuvant therapy
Number of subjects: 688

Group type: COMPARATOR
Intervention: Adjuvant therapy alone (control)
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: Preoperative hepatic and regional arterial chemotherapy (PHRAC)
Number of subjects: 688
Study: 32936427

Group type: EXPERIMENTAL
Intervention: TRZ30 (10 mg three times daily for 8 weeks)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: TRZ60 (20 mg three times daily for 8 weeks)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141

Group type: COMPARATOR
Intervention: TRZ30 vs Placebo
Number of subjects: 141
Study: 36209217

Group type: EXPERIMENTAL
Intervention: Periosteum coverage
Number of subjects: 36

Group type: COMPARATOR
Intervention: Traditional technique
Number of subjects: 36
Study: 34411045

Group type: EXPERIMENTAL
Intervention: Visual estimation of hypoperfusion
Number of subjects: 122

Group type: COMPARATOR
Intervention: HipVasc software measurements
Number of subjects: 122
Study: 34881669

Group type: EXPERIMENTAL
Intervention: 12-week group self-management exercise and education program
Number of subjects: 23

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 23
Study: 33060615

Group type: EXPERIMENTAL
Intervention: Case method learning
Number of subjects: 425

Group type: COMPARATOR
Intervention: Traditional lectures
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Smoking cessation
Number of subjects: 425
Study: 35101808

Group type: EXPERIMENTAL
Intervention: Hybrid simulation (standardized patient and task-trainer) in a transport ambulance
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Task-trainer in skill lab
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no education)
Number of subjects: 45
Study: 33458839

Group type: EXPERIMENTAL
Intervention: Movement pattern training (MoveTrain)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Traditional strength/flexibility (Standard)
Number of subjects: 46
Study: 34586927

Group type: EXPERIMENTAL
Intervention: TIGER training (20 minutes) plus 20 minutes of task-specific motor training
Number of subjects: 34

Group type: COMPARATOR
Intervention: Traditional occupational therapy (20 minutes)
Number of subjects: 34
Study: 32101207

Group type: COMPARATOR
Intervention: 0 g RS4
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 10 g RS4
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 20 g RS4
Number of subjects: 31
Study: 33121886

Group type: EXPERIMENTAL
Intervention: Interactive sessions
Number of subjects: 53

Group type: COMPARATOR
Intervention: Traditional lectures
Number of subjects: 53
Study: 33239000

Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35222287

Group type: EXPERIMENTAL
Intervention: Real-time flash glucose monitoring
Number of subjects: 172

Group type: COMPARATOR
Intervention: Retrospective flash glucose monitoring
Number of subjects: 172
Study: 32653532

Group type: EXPERIMENTAL
Intervention: Reciproc Blue (RB)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: XP-endo Shaper (XP-S)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: XP-endo Finisher (XP-F)
Number of subjects: 28
Study: 34938354

Group type: EXPERIMENTAL
Intervention: Bisphosphonate drugs
Number of subjects: 104

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 104
Study: 33051230

Group type: EXPERIMENTAL
Intervention: Mail survey (Group A, n=4999)
Number of subjects: 6999

Group type: COMPARATOR
Intervention: Web-based survey (Group B, n=2000)
Number of subjects: 6999

Group type: EXPERIMENTAL
Intervention: Both groups (mail and web)
Number of subjects: 6999
Study: 35236723

Group type: EXPERIMENTAL
Intervention: Intensive surveillance (AFB every 6 months)
Number of subjects: 364

Group type: COMPARATOR
Intervention: Standard surveillance (CT and AFB at 36 months)
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Smoking cessation
Number of subjects: 364
Study: 32708737

Group type: EXPERIMENTAL
Intervention: RNA-seq analysis of transcriptional dynamics and identification of key genes involved in grain filling.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Validation of expression levels of seven randomly selected DEGs by qRT-PCR.
Number of subjects: 0
Study: 35432844

Group type: EXPERIMENTAL
Intervention: Insulin combined with Traditional Chinese Medicine (TCM) prescription
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nursing intervention based on control group (Insulin + TCM)
Number of subjects: 60
Study: 32798568

Group type: EXPERIMENTAL
Intervention: Aquatic Exercise (AQ, n = 9)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Aquatic Exercise + Grape Juice (AQ+GJ, n = 10)
Number of subjects: 19
Study: 35240988

Group type: EXPERIMENTAL
Intervention: Comprehensive Geriatric Assessment (CGA) during hospital stay
Number of subjects: 155

Group type: COMPARATOR
Intervention: Care at an ordinary medical hospital ward (Control)
Number of subjects: 155
Study: 32007833

Group type: EXPERIMENTAL
Intervention: Continuum model of alcohol problems
Number of subjects: 597

Group type: COMPARATOR
Intervention: Binary disease model
Number of subjects: 597

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 597
Study: 35471644

Group type: EXPERIMENTAL
Intervention: Trial-based psychosocial intervention (INT) focused on building resilience to stress, improving mental health, and reducing condomless anal sex (CAS). Cost: $49.37/participant.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Status quo HIV care (SQ)
Number of subjects: 0
Study: 33902415

Group type: EXPERIMENTAL
Intervention: RPV/TDF/3TC
Number of subjects: 40

Group type: COMPARATOR
Intervention: EFV/TDF/3TC
Number of subjects: 40
Study: 34823258

Group type: EXPERIMENTAL
Intervention: CADe (Computer-Aided Detection)
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: CAQ (Computer-Aided Quality Improvement)
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: CADe plus CAQ (COMBO)
Number of subjects: 1076

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1076
Study: 33247001

Group type: EXPERIMENTAL
Intervention: e‐coachER (web-based support)
Number of subjects: 450

Group type: COMPARATOR
Intervention: usual ERS alone (control)
Number of subjects: 450
Study: 36247927

Group type: EXPERIMENTAL
Intervention: Mazdutide 9 mg (3 mg weeks 1-4; 6 mg weeks 5-8; 9 mg weeks 9-12)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Mazdutide 10 mg (2.5 mg weeks 1-4; 5 mg weeks 5-8; 7.5 mg weeks 9-12; 10 mg weeks 13-16)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Mazdutide
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 34536445

Group type: EXPERIMENTAL
Intervention: Lowest third of heart rate reserve
Number of subjects: 1967

Group type: EXPERIMENTAL
Intervention: Lowest third of heart rate recovery
Number of subjects: 1967

Group type: COMPARATOR
Intervention: Highest third of heart rate reserve and recovery (control group)
Number of subjects: 1967

Group type: EXPERIMENTAL
Intervention: Increment in heart rate reserve and recovery
Number of subjects: 1967
Study: 616567804

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation exercise
Number of subjects: 282

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 282
Study: 33504976

Group type: EXPERIMENTAL
Intervention: Male physicians managing female patients
Number of subjects: 1186

Group type: EXPERIMENTAL
Intervention: Male physicians managing male patients
Number of subjects: 1186

Group type: EXPERIMENTAL
Intervention: Female physicians managing female patients
Number of subjects: 1186

Group type: EXPERIMENTAL
Intervention: Female physicians managing male patients
Number of subjects: 1186

Group type: EXPERIMENTAL
Intervention: Overall management by male physicians
Number of subjects: 1186

Group type: EXPERIMENTAL
Intervention: Overall management by male physicians vs female physicians
Number of subjects: 1186
Study: 33168910

Group type: EXPERIMENTAL
Intervention: Mouthwash (rinsing, gargling and spraying twice daily for 14 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard treatment (antibiotics)
Number of subjects: 12
Study: 32122273

Group type: EXPERIMENTAL
Intervention: Caffeine mouth rinse (6 mg/kg)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Glucose mouth rinse (6.4%)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo mouth rinse
Number of subjects: 27

Group type: COMPARATOR
Intervention: Ramadan effect
Number of subjects: 27
Study: 35643873

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (20 µg/day)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: High protein yogurt (10 g protein/100 g)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Normal protein yogurt (3.5 g protein/100 g)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Sit-to-stand test
Number of subjects: 183
Study: 34350193

Group type: EXPERIMENTAL
Intervention: Proxalutamide 200 mg/day for up to 7 days
Number of subjects: 268

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 268
Study: 35047059

Group type: EXPERIMENTAL
Intervention: Autoimmune cell therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 60
Study: 34684116

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (cholecalciferol: 2000 IU/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 32018274

Group type: EXPERIMENTAL
Intervention: PC6 pressure (4 times a day, for 10 min)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 90

Group type: COMPARATOR
Intervention: Medication with vitamin B6 and metoclopramide
Number of subjects: 90
Study: 34673449

Group type: EXPERIMENTAL
Intervention: Computer-based therapy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Therapist-mediated therapy
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 22
Study: 36418112

Group type: EXPERIMENTAL
Intervention: Biodegradable polymer everolimus-eluting stent (BP-EES)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Durable polymer everolimus-eluting stent (DP-EES)
Number of subjects: 20
Study: 32809921

Group type: EXPERIMENTAL
Intervention: Constructivist physical education intervention
Number of subjects: 1256
Study: 33451495

Group type: EXPERIMENTAL
Intervention: Kinase activity
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Individual kinases
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Phosphorylation of known activating or inhibitory sites on kinases
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Motif-based analysis
Number of subjects: 150
Study: 36214314

Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block
Number of subjects: 78

Group type: COMPARATOR
Intervention: Transversus abdominis plane (TAP) block
Number of subjects: 78
Study: 36592517

Group type: EXPERIMENTAL
Intervention: 0.1 mg/L Schisandrin B
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5 mg/L Schisandrin B
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (0 mg/L Schisandrin B)
Number of subjects: 0
Study: 33772456

Group type: EXPERIMENTAL
Intervention: Pentoxiphylline (PTX) 400 mg thrice daily and Vitamin E (VE) 400 IU twice daily (PTVE group)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Vitamin E (VE) alone (VE group)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Pentoxiphylline (PTX) and Vitamin E (VE) combination (PTVE group)
Number of subjects: 69
Study: 32615392

Group type: EXPERIMENTAL
Intervention: Probiotics (6 g/d for 6 months)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Synbiotics (6 g/d for 6 months)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (maltodextrin, 6 g/d for 6 months)
Number of subjects: 120
Study: 36245316

Group type: EXPERIMENTAL
Intervention: Congruence Couple Therapy (CCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment‐as‐Usual (TAU)
Number of subjects: 0
Study: 34791756

Group type: EXPERIMENTAL
Intervention: Natriuresis-guided therapy
Number of subjects: 310

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 310
Study: 33327237

Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual rehabilitation program
Number of subjects: 0
Study: 36150694

Group type: EXPERIMENTAL
Intervention: Cryolipolysis (60 minutes, -9°C)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Surgical flap contouring
Number of subjects: 10
Study: 33438146

Group type: EXPERIMENTAL
Intervention: audio with phonocardiogram tracings (combined group)
Number of subjects: 135

Group type: COMPARATOR
Intervention: audio group (control)
Number of subjects: 135
Study: 32739080

Group type: EXPERIMENTAL
Intervention: Bicompartmental knee arthroplasty (BCA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 80
Study: 36094367

Group type: EXPERIMENTAL
Intervention: End-range Maitland mobilization (EMGr)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Not end-range Maitland mobilization (nEMGr)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Sham manual therapy technique (CG)
Number of subjects: 66
Study: 32985592

Group type: COMPARATOR
Intervention: Cover Group (CG)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Fill Group (FG)
Number of subjects: 28
Study: 33436684

Group type: EXPERIMENTAL
Intervention: Diffuse Reflectance Spectroscopy (DRS) probing superficial colorectal tissue
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Diffuse Reflectance Spectroscopy (DRS) probing deeper tissue layers
Number of subjects: 47
Study: 32383572

Group type: EXPERIMENTAL
Intervention: DfPD®-based dance classes (one hour, twice weekly for 12 weeks)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: DfPD®-based dance classes
Number of subjects: 33
Study: 33739319

Group type: EXPERIMENTAL
Intervention: Exercise group (n=58)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Counseling group (n=53)
Number of subjects: 150
Study: 32835880

Group type: EXPERIMENTAL
Intervention: 37% phosphoric acid (PA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: MBP using PDT
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser (NYL)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Air abrasion (AA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG (ECYL)
Number of subjects: 50
Study: 34686942

Group type: EXPERIMENTAL
Intervention: Novel SDM tool based on the SHARE Approach; consultation time was 11 minutes longer (p < 0.01).
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no SDM tool); consultation time was shorter than experimental group.
Number of subjects: 18
Study: 33530249

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation via helmet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-invasive ventilation via face mask
Number of subjects: 0
Study: 34963309

Group type: EXPERIMENTAL
Intervention: Anodal tPCS at 75 Hz
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Anodal tPCS at 4 Hz
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham a-tPCS
Number of subjects: 17
Study: 32359018

Group type: EXPERIMENTAL
Intervention: Microneedling
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fractional Er:YAG laser
Number of subjects: 24
Study: 33932294

Group type: EXPERIMENTAL
Intervention: TRAINING (6-week group-format advanced training program including plyometric, strengthening, and agility exercises)
Number of subjects: 46

Group type: COMPARATOR
Intervention: NoTRAINING (age- and sex-matched patients who did not participate in advanced training)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: TRAINING
Number of subjects: 46

Group type: COMPARATOR
Intervention: NoTRAINING
Number of subjects: 46
Study: 32940718

Group type: EXPERIMENTAL
Intervention: Virtual dissection
Number of subjects: 100

Group type: COMPARATOR
Intervention: Textbooks (control)
Number of subjects: 100
Study: 32026714

Group type: EXPERIMENTAL
Intervention: Periodontitis (PD ≥4 mm and CAL ≥1 mm)
Number of subjects: 2435

Group type: EXPERIMENTAL
Intervention: Mean percentage PD ≥4 mm
Number of subjects: 2435

Group type: EXPERIMENTAL
Intervention: Gingival Index (GI)
Number of subjects: 2435

Group type: EXPERIMENTAL
Intervention: Plaque Index (PI)
Number of subjects: 2435

Group type: COMPARATOR
Intervention: Tooth brushing
Number of subjects: 2435
Study: 35486221

Group type: EXPERIMENTAL
Intervention: MALND
Number of subjects: 996

Group type: COMPARATOR
Intervention: CALND
Number of subjects: 996
Study: 33906234

Group type: COMPARATOR
Intervention: Single-dose ALB (400 mg)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Single-dose ALB (400 mg) plus IVM (600 μg/kg)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: ALB (400 mg) for 3 consecutive days
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: ALB (400 mg) plus IVM (600 μg/kg) for 3 consecutive days
Number of subjects: 176
Study: 34872341

Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis combined with EVT (combination-therapy group)
Number of subjects: 633

Group type: COMPARATOR
Intervention: EVT alone
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Combination-therapy group
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Alteplase treatment
Number of subjects: 633
Study: 32645109

Group type: EXPERIMENTAL
Intervention: Combined protocol (2 sachets of RUTF per day for MUAC < 11.5 cm and/or edema; 1 sachet of RUTF per day for MUAC 11.5 to <12.5 cm)
Number of subjects: 4070

Group type: COMPARATOR
Intervention: Standard care (weight-based RUTF for SAM; RUSF for MAM)
Number of subjects: 4070

Group type: EXPERIMENTAL
Intervention: Combined protocol
Number of subjects: 4070

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 4070
Study: 34589541

Group type: EXPERIMENTAL
Intervention: MRI-guided BT
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard BT
Number of subjects: 14
Study: 36098582

Group type: EXPERIMENTAL
Intervention: Early catheter removal (3 days after surgery)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard catheterization time (7 days after surgery)
Number of subjects: 30
Study: 33559518

Group type: EXPERIMENTAL
Intervention: Baby QOL narratives
Number of subjects: 1966

Group type: EXPERIMENTAL
Intervention: Baby QOL + Family QOL narratives
Number of subjects: 1966

Group type: EXPERIMENTAL
Intervention: Family QOL narratives
Number of subjects: 1966

Group type: COMPARATOR
Intervention: Control: no narratives
Number of subjects: 1966
Study: 35132653

Group type: EXPERIMENTAL
Intervention: Person-centred and theory-based educational intervention
Number of subjects: 312

Group type: COMPARATOR
Intervention: Conventional information/instruction (Control)
Number of subjects: 312
Study: 32050853

Group type: EXPERIMENTAL
Intervention: WBV + BFR
Number of subjects: 20

Group type: COMPARATOR
Intervention: WBV
Number of subjects: 20
Study: 35226099

Group type: EXPERIMENTAL
Intervention: Low-dose rh insulin (400-μIU/mL milk)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: High-dose rh insulin (2000-μIU/mL milk)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303
Study: 33750266

Group type: EXPERIMENTAL
Intervention: Probiotic acidophilus milk (100 g/day, 107 cfu/g)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Freshly prepared 'dahi' (100 g/day, 107 cfu/g)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Thermal processed buffalo milk (100 ml/day)
Number of subjects: 45
Study: 36069662

Group type: EXPERIMENTAL
Intervention: Outsmart HPV intervention
Number of subjects: 1227

Group type: COMPARATOR
Intervention: Standard HPV vaccination information online (control)
Number of subjects: 1227
Study: 32290148

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (30 min at 60% maximal aerobic power)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Anaerobic exercise (30 s Wingate test)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combined exercise (anaerobic and aerobic)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (baseline measurements)
Number of subjects: 10
Study: 34038228

Group type: EXPERIMENTAL
Intervention: Levodopa
Number of subjects: 0
Study: 36384551

Group type: EXPERIMENTAL
Intervention: Customised care in response to mental health risk
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Customised care in response to domestic violence
Number of subjects: 352

Group type: COMPARATOR
Intervention: Standard care (not specified)
Number of subjects: 352
Study: 32683390

Group type: EXPERIMENTAL
Intervention: Topical gel containing 0.2% chlorhexidine, 0.5% chitosan, 5% dexpanthenol, 0.15% allantoin, and 0.01% sodium saccharin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 32394355

Group type: EXPERIMENTAL
Intervention: Harvest height of 15 cm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Harvest height of 25 cm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Harvest height of 35 cm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Harvest height of 45 cm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Residual stalks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing harvest height
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Residuals
Number of subjects: 0
Study: 32007714

Group type: EXPERIMENTAL
Intervention: CBOP/BEP (carboplatin, bleomycin, vincristine and cisplatin)
Number of subjects: 89

Group type: COMPARATOR
Intervention: BEP (bleomycin, etoposide and cisplatin)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Stabilising chemotherapy
Number of subjects: 89
Study: 34731268

Group type: EXPERIMENTAL
Intervention: GET 73
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33260292

Group type: EXPERIMENTAL
Intervention: Strong parental support for breakfast as the main daily meal
Number of subjects: 1149

Group type: EXPERIMENTAL
Intervention: Paternal education
Number of subjects: 1149

Group type: EXPERIMENTAL
Intervention: Maternal education
Number of subjects: 1149

Group type: EXPERIMENTAL
Intervention: Insufficient sleep
Number of subjects: 1149

Group type: EXPERIMENTAL
Intervention: BMI <25 kg/m2
Number of subjects: 1149
Study: 35049111

Group type: EXPERIMENTAL
Intervention: 90° bend angle
Number of subjects: 136

Group type: COMPARATOR
Intervention: 70° bend angle
Number of subjects: 136
Study: 33427851

Group type: EXPERIMENTAL
Intervention: Nurse navigator‐led ACP pathway
Number of subjects: 759

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 759